Mechanism of Action

Advanced Oxidative Reaction

CLYRA Medical Technologies products feature the most potent, broadest spectrum anti- bacterial, anti-fungal & anti-viral advanced oxidation system known to the world.  With no known acquired resistance capability we deliver it on demand, when you need it, in the right dose so that it’s safe and effective.

iStock_000013328467_Small

Scientific Data

 

CLYRA™ technology causes the instantaneous release of a powerful yet safe antimicrobial in measured doses when it is mixed by water from any source, including a wound exudate caused to insult an impregnated bandage. CLYRA has characterized this antimicrobial in conformance with FDA standards, and confirms that the efficacy and safety of this antimicrobial is in conformance with standards and literature on the subject. CLYRA Medical Technologies continues to push the envelope with efficacy and safety testing.

Formulations of CLYRA’s antimicrobial hydrogel and liquid wound cleanser products have passed rigorous third party laboratory testing validating both efficacy and safety. Independent testing has verified both rapid and effective control against a host of dangerous pathogens commonly encountered in the wound care field. Testing of the company’s liquid formula verified efficacy against antimicrobial resistant species referred to by the CDC as the “ESKAPE” pathogens – enterococcus faecium (VRE), staphylococcus aureus (MRSA), klebsiella species, acinetobacter baumannii, pseudomonas aeruginosa, and enterobacter.

 

Contact Us

Would you like more information about Clyra Medical Technologies. Please contact us.
MENU